<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetes Care</journal-id><journal-id journal-id-type="iso-abbrev">Diabetes Care</journal-id><journal-id journal-id-type="hwp">diacare</journal-id><journal-id journal-id-type="pmc">dcare</journal-id><journal-id journal-id-type="publisher-id">Diabetes Care</journal-id><journal-title-group><journal-title>Diabetes Care</journal-title></journal-title-group><issn pub-type="ppub">0149-5992</issn><issn pub-type="epub">1935-5548</issn><publisher><publisher-name>American Diabetes Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28420697</article-id><article-id pub-id-type="pmc">5439411</article-id><article-id pub-id-type="publisher-id">er06a</article-id><article-id pub-id-type="doi">10.2337/dc17-er06a</article-id><article-categories><subj-group subj-group-type="heading"><subject>Errata</subject></subj-group></article-categories><title-group><article-title>Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:<related-article id="d35e32" related-article-type="corrected-article" ext-link-type="doi" xlink:href="10.2337/dc15-2145" vol="39" page="455">455&#x02013;464</related-article></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mita</surname><given-names>Tomoya</given-names></name></contrib><contrib contrib-type="author"><name><surname>Katakami</surname><given-names>Naoto</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shiraiwa</surname><given-names>Toshihiko</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yoshii</surname><given-names>Hidenori</given-names></name></contrib><contrib contrib-type="author"><name><surname>Onuma</surname><given-names>Tomio</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kuribayashi</surname><given-names>Nobuichi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Osonoi</surname><given-names>Takeshi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kaneto</surname><given-names>Hideaki</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kosugi</surname><given-names>Keisuke</given-names></name></contrib><contrib contrib-type="author"><name><surname>Umayahara</surname><given-names>Yutaka</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yamamoto</surname><given-names>Tsunehiko</given-names></name></contrib><contrib contrib-type="author"><name><surname>Matsumoto</surname><given-names>Kazunari</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yokoyama</surname><given-names>Hiroki</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tsugawa</surname><given-names>Mamiko</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gosho</surname><given-names>Masahiko</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shimomura</surname><given-names>Iichiro</given-names></name></contrib><contrib contrib-type="author"><name><surname>Watada</surname><given-names>Hirotaka</given-names></name></contrib><on-behalf-of>on behalf of the Collaborators on the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) Trial</on-behalf-of></contrib-group><pub-date pub-type="ppub"><month>6</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>18</day><month>4</month><year>2017</year></pub-date><volume>40</volume><issue>6</issue><fpage seq="2">808</fpage><lpage>808</lpage><permissions><copyright-statement>&#x000a9; 2017 by the American Diabetes Association.</copyright-statement><copyright-year>2017</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="vor" start_date="2017-05-22">http://www.diabetesjournals.org/content/license</ali:license_ref><license-p>Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at <ext-link ext-link-type="uri" xlink:href="http://www.diabetesjournals.org/content/license">http://www.diabetesjournals.org/content/license</ext-link>.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="dc17er06a.pdf"/><counts><page-count count="1"/></counts></article-meta></front><body><p>In the Research Design and Methods section of the article mentioned above, the measurement of carotid intima-media thickness (IMT) was described as follows: &#x0201c;The software system averages 60 points of IMT values in the segment 2 cm proximal to the dilation of the carotid bulb (mean-IMT-CCA).&#x0201d; The sentence should read: &#x0201c;The software system averages &#x0223c;200 points of IMT values in the segment 2 cm proximal to the dilation of the carotid bulb (mean-IMT-CCA).&#x0201d;</p><p>The authors believe that this correction will not affect the results obtained in the study, and they regret the error.</p><p>The online version of the article has been corrected.</p></body></article>